These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21264450)

  • 21. Autoimmune Hemorrhaphilia Resulting from Autoantibody against the A Subunit of Factor XIII.
    Uchida E; Watanabe K; Arai R; Yamamoto M; Souri M; Osaki T; Ichinose A; Miura O; Koyama T
    Intern Med; 2015; 54(18):2383-7. PubMed ID: 26370866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Report of a patient with chronic intractable autoimmune hemorrhaphilia due to anti-factor XIII/13 antibodies who died of hemorrhage after sustained clinical remission for 3 years.
    Kotake T; Souri M; Takada K; Kosugi S; Nakata S; Ichinose A
    Int J Hematol; 2015 Jun; 101(6):598-602. PubMed ID: 25663511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ETRO Working Party on Factor XIII questionnaire on congenital factor XIII deficiency in Europe: status and perspectives. Study Group.
    Seitz R; Duckert F; Lopaciuk S; Muszbek L; Rodeghiero F; Seligsohn U
    Semin Thromb Hemost; 1996; 22(5):415-8. PubMed ID: 8989825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A patient whose factor XIII level was decreased by double filtrate plasmapheresis and successfully recovered by infusion of factor XIII concentrate.
    Hanafusa N; Aozasa N; Fujita T
    Ther Apher Dial; 2010 Aug; 14(4):432-3. PubMed ID: 20649765
    [No Abstract]   [Full Text] [Related]  

  • 25. Monocytes of patients congenitally deficient in plasma factor XIII lack factor XIII subunit a antigen and transglutaminase activity.
    Muszbek L; Adány R; Kávai M; Boda Z; Lopaciuk S
    Thromb Haemost; 1988 Apr; 59(2):231-5. PubMed ID: 2898817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced levels of coagulation factor XIII in patients with advanced tumor disease.
    Born P; Lippl F; Ulm K; Gerein P; Lersch C; Eckel F; Fischer G; Sandschin W; Dlaska U; Classen M
    Hepatogastroenterology; 2000; 47(31):194-8. PubMed ID: 10690608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A reversed activity staining procedure for detection of an acquired antibody against factor XIII in a girl with factor XIII deficiency.
    Seiving B; Henriksson P; Stenberg P; Nilsson IM
    Br J Haematol; 1992 Oct; 82(2):414-6. PubMed ID: 1419823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acquired factor XIII inhibitor: clinical features, treatment, fibrin structure and epitope determination.
    Luo YY; Zhang GS
    Haemophilia; 2011 May; 17(3):393-8. PubMed ID: 21323797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and laboratory features of congenital factor XIII deficiency.
    Al-Sharif FZ; Aljurf MD; Al-Momen AM; Ajlan AM; Musa MO; Al-Nounou RM; Al-Mohareb FI; Alomar HM; Zaidi ZZ; Al-Zahrani HA
    Saudi Med J; 2002 May; 23(5):552-4. PubMed ID: 12070580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracranial hemorrhage pattern in the patients with factor XIII deficiency.
    Naderi M; Zarei T; Haghpanah S; Eshghi P; Miri-Moghaddam E; Karimi M
    Ann Hematol; 2014 Apr; 93(4):693-7. PubMed ID: 24149912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acquired coagulation factor XIII deficiency: a case report.
    Jia Y; Hu H; Wei B
    Blood Coagul Fibrinolysis; 2016 Jun; 27(4):454-6. PubMed ID: 26588447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A short half-life of the administered factor XIII (FXIII) concentrates after the first replacement therapy in a newborn with severe congenital FXIII deficiency.
    Fujii N; Souri M; Ichinose A
    Thromb Haemost; 2012 Mar; 107(3):592-4. PubMed ID: 22234520
    [No Abstract]   [Full Text] [Related]  

  • 33. [A case with SLE showing acquired low plasma F.XIII level followed by severe hematoma characteristic of F.XIII deficiency].
    Okubo S; Yamano M; Yasunaga K
    Rinsho Ketsueki; 1988 Sep; 29(9):1522-6. PubMed ID: 3216525
    [No Abstract]   [Full Text] [Related]  

  • 34. [Substitution with blood coagulation factor XIII concentrates in patients with acute leukemia].
    Rasche H
    Beitr Infusionther Klin Ernahr; 1986; 15():179-86. PubMed ID: 3530242
    [No Abstract]   [Full Text] [Related]  

  • 35. In vitro factor XIII supplementation increases clot firmness in Rotation Thromboelastometry (ROTEM).
    Theusinger OM; Baulig W; Asmis LM; Seifert B; Spahn DR
    Thromb Haemost; 2010 Aug; 104(2):385-91. PubMed ID: 20431856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factor XIII deficiency.
    Hsieh L; Nugent D
    Haemophilia; 2008 Nov; 14(6):1190-200. PubMed ID: 19141159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An unusual clinical presentation of factor XIII deficiency and issues relating to the monitoring of factor XIII replacement therapy.
    Dargaud Y; de Mazancourt P; Rugeri L; Hanss M; Borg JY; Gaucherand P; Negrier C; Trzeciak C
    Blood Coagul Fibrinolysis; 2008 Jul; 19(5):447-52. PubMed ID: 18600098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acquired Factor XIII inhibitor associated with mantle cell lymphoma.
    Nixon CP; Prsic EH; Guertin CA; Stevenson RL; Sweeney JD
    Transfusion; 2017 Mar; 57(3):694-699. PubMed ID: 27917497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autoimmune acquired factor XIII deficiency in Japan 2021 update: Focused on annual incidence and clinical features.
    Ichinose A; Osaki T; Souri M
    Haemophilia; 2022 Sep; 28(5):e121-e124. PubMed ID: 35768905
    [No Abstract]   [Full Text] [Related]  

  • 40. [Fibrin stabilization and factor XIII substitution in malignant tumors (author's transl)].
    Zöller H
    Arzneimittelforschung; 1977 Jul; 27(7):1500-2. PubMed ID: 578483
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.